Verastem | VSTM - Ebit


Verastem reported $-37.03M in EBIT for its fiscal quarter ending in September of 2024.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Curis USD -12.37M 230K Sep/2023
Cytokinetics USD -178.37M 11.61M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
Laboratory Of America USD 382M 11M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025
Verastem USD -37.03M 6M Sep/2024